These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 35794546)
1. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance. Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546 [TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis. Kang Y; Zhu X; Wang X; Liao S; Jin M; Zhang L; Wu X; Zhao T; Zhang J; Lv J; Zhu D Front Oncol; 2021; 11():641184. PubMed ID: 33816287 [TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma. Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556 [TBL] [Abstract][Full Text] [Related]
4. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
5. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma. Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191 [TBL] [Abstract][Full Text] [Related]
6. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
7. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Yang M; He H; Peng T; Lu Y; Yu J Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038 [TBL] [Abstract][Full Text] [Related]
8. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes. Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
10. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis. Zhao M; Chen Z; Zheng Y; Liang J; Hu Z; Bian Y; Jiang T; Li M; Zhan C; Feng M; Wang Q J Cancer Res Clin Oncol; 2020 Jun; 146(6):1463-1472. PubMed ID: 32221746 [TBL] [Abstract][Full Text] [Related]
11. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction. Wang Z; Niu D Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
13. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
14. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
15. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma. Lvu W; Fei X; Chen C; Zhang B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165 [TBL] [Abstract][Full Text] [Related]
16. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
17. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
18. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related]
19. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma. Lin J; Cao Z; Yu D; Cai W Front Genet; 2021; 12():709133. PubMed ID: 34603375 [TBL] [Abstract][Full Text] [Related]
20. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]